The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected

    Oncotarget, 2016.

    Cited by: 0|Bibtex|Views0|Links
    WOS
    Keywords:
    lung cancermalignant pleural effusionprognosissurgerysurveillance epidemiology and end-results database

    Abstract:

    Although non-small cell lung cancer (NSCLC) with malignant pleural effusion (M1a) is generally contraindicated for surgery, several reports have demonstrated favorable prognosis. This study aimed to describe the results of surgical intervention in this disease. In this retrospective study, we evaluated NSCLC patients with ipsilateral mali...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments